When was PointCross founded?

PointCross was founded in 2000 and raised its 1st funding round 7 years after it was founded.

Where is PointCross located?

PointCross is headquartered in Foster City, United States. It is registered at 3rd Floor BVR Lake Front No 1/4 Veerannapalya Outer Ring Road, bangalore, Karnataka, India, 560045.

Who is the current CEO of PointCross?

Suresh Madhavan and Suresh Madhavan s of PointCross.

How many employees does PointCross have?

As of May 31, 2026, the latest employee count at PointCross is 172.

Is PointCross a funded company?

PointCross is a funded company, having raised a total of $120K across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Feb 13, 2007.

When was the latest funding round of PointCross?

PointCross' latest funding was a $***** Seed round on 2007, with participation from 0 investor. Its primary sector is Biopharma Outsourcing. In United States, the Biopharma Outsourcing sector has seen $411M in funding in 2026 to date.

Where does PointCross rank among its competitors?

PointCross ranks 4th amongst 46 active competitors, of which 3 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Conifer Point, which secured $2.64M in Jun, 2025.

Who are the top competitors of PointCross?

PointCross' top competitors include Aganitha, HQS Quantum Simulations and Cellumen. Among them, Conifer Point secured the most recent funding round in June, 2025.

PointCross - 2026 Company Profile, Team, Funding & Competitors

PointCross is a seed company based in Foster City (United States), founded in 2000. It operates as a Life science software solutions for clinical data automation and regulatory submissions. PointCross has raised $120K in funding. The company has 46 active competitors, including 3 funded and 2 that have exited. Its top competitors include companies like Aganitha, HQS Quantum Simulations and Cellumen.

Company Details

Life science software solutions for clinical data automation and regulatory submissions. We provide cutting-edge technology solutions designed to streamline all aspects of clinical data automation for the global BioPharma industry. Our robust platform offers data management and curation, secure and scalable warehousing, standardization and harmonization to ensure compliance with regulatory submission standards, and advanced analytics and visualization to transform data into actionable insights. We offer SEND services, SEND dataset preparation, QC of SEND datasets, digital study report generation, and automated SDTM generation. Our products include a solutions platform, data repository, smart transformer, and regulatory submission tools. We specialize in data standardization, data quality assurance, and data concierge services. We also offer digitization, analysis, and warehousing of legacy clinical trial data. Our platform is RAG-enabled with AI LLM technology, transforming how users access clinical trial and nonclinical study data through plain English queries via a Large Language Model chat interface.

Website: pointcrosslifesciences.com
Social
Email ID: *****@pointcrosslifesciences.com
Phone Number: +1 **********
Registered Address: 3rd Floor BVR Lake Front No 1/4 Veerannapalya Outer Ring Road, bangalore, Karnataka, India, 560045

Key Metrics

Founded Year

2000

Location

Foster City, United States

Stage

Seed

Total Funding

$120K in 2 rounds

Latest Funding Round

Seed, 2007, $*****

Ranked

4^th among 46 active competitors

Employee Count

172 as on May 31, 2026

Similar Companies

Aganitha & 54 more

View PointCross' full profile

PointCross is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
POINTCROSS .COM PRIVATE LIMITED CIN: U72900KA2000PTC026637 , India, Active	Mar 16, 2000	₹10 - ₹50 Cr (As on Mar 31, 2025)	-

PointCross has raised a total funding of $120K over 2 rounds. Its first funding round was on Feb 13, 2007.

Here is the list of recent funding rounds of PointCross:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
2007	4086	Seed	3394	9852	2235	5061
Feb 13, 2007	6739992	Seed	9692675	7340276	1375473	4227230

Access funding benchmarks and valuations. Sign up today!

View details of PointCross's funding rounds and investors

PointCross' employee count trend

PointCross has 172 employees as of May 26. Here is PointCross's employee count trend over the years:

Uncover PointCross' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PointCross include Aganitha, HQS Quantum Simulations and Cellumen. Here is the list of Top 10 competitors of PointCross, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Aganitha 2017, Hyderabad (India), Funding Raised	Provider of AI-powered drug discovery and development solutions	-	C-CAMP, Technextchallenge & 1 others	47/100
2nd	HQS Quantum Simulations 2017, Karlsruhe (Germany), Series A	Developer of quantum simulation software for spectroscopy and related techniques	$16.2M	b2venture, HTGF & 10 others	43/100
3rd	Cellumen 2004, Pittsburgh (United States), Acquired	Biomarkers, antibodies, assay kits, and reagents for life science research	$12.2M	Novitas Capital, Innovation Works & 2 others	35/100
4th	PointCross 2000, Foster City (United States), Seed	Life science software solutions for clinical data automation and regulatory submissions	$120K	-	33/100
5th	ConcR 2018, London (United Kingdom), Seed	Provider of a platform predicting therapeutic response and outcome for cancer	$3.07M	Avonmore Developments, Cambridge Angels & 6 others	31/100
6th	Novomol 2017, Lorrach (Germany), Unfunded	Computational drug discovery services	-	-	29/100
7th	Kinentia Biosciences 2007, Albany (United States), Unfunded	Drug discovery and development services, chemoinformatics, and chemical catalog provider	-	-	27/100
8th	Conifer Point 2015, Doylestown (United States), Acquired	Developer of new drugs using custom fragment-based drug design software	-	HHS	25/100
9th	Emergentec 2002, Vienna (Austria), Funding Raised	Computational solutions and consulting for better decision making in biomarker, target and drug development.	-	Europa	24/100
10th	InSilicoMinds 2021, Hyderabad (India), Funding Raised	Provider of AI and advanced modeling and simulation solutions	-	Unusual Innovation	24/100